MilliporeSigma Expands Distribution Agreement with Public Health England

News Release June 15, 2017 Your Contact: Karen Tiano +1 978-495-0093 MilliporeSigma Expands Distribution Agreement with Public Health England MilliporeSigma to become global distributor of the European Bank for induced pluripotent Stem Cells, excluding Japan Extension of relationship with Public Health England for global distribution of cost-efficient, authenticated cell lines Billerica, Massachusetts, June 15, 2017... Read more

MilliporeSigma Awarded its First CRISPR Patent by Australian Patent Office

News Release June 14, 2017 Your Contact: Karen Tiano +1 978-495-0093 MilliporeSigma Awarded its First CRISPR Patent by Australian Patent Office Patent covers successful integration of an external DNA sequence into the chromosome of eukaryotic cells using CRISPR Similar patents pending in other countries; anticipate favorable outcomes Billerica, Massachusetts, June 14, 2017 — MilliporeSigma today announced... Read more

Molecular Devices Launches ImageXpress Nano System and CellReporterXpress Software

ImageXpress Nano System makes automated imaging accessible for every lab conducting cellular imaging research Sunnyvale, Calif. – June 15, 2017. Molecular Devices, LLC, a leader in protein and cell biology technologies, today announced the launch of its ImageXpress® Nano Automated Imaging System and CellReporterXpress Image Acquisition and Analysis Software. Based upon feedback from our clients and... Read more

New Immobilized Lux Chiral LC-SFC Selector from Phenomenex Delivers Broad Enantioselectivity

Torrance, Calif. (June 12, 2017) – Phenomenex Inc., a global leader in the research and manufacture of advanced technologies for the separation sciences, expands its Lux chiral LC/SFC column family with new immobilized Lux 5µm i-Amylose-1 and Lux 3µm i-Amylose-1 media. During the manufacturing of Lux immobilized media, a chemical crosslinking is formed between the... Read more

Waters and Andrews Alliance Sign Co-Marketing Agreement: Firms to Co-Market New Semi-Automated Sample Preparation Approach for Protein Therapeutics Glycosylation Profiling

Waters Corporation (NYSE:WAT) and Andrew Alliance today announced they have signed an agreement that will bring drug development scientists an easy-to-use, semi-automated sample preparation approach for released N-glycan profiling and analysis by LC and LC-MS. Under the co-marketing agreement, Waters will combine its existing Glycoworks™ RapiFluor-MS™ (RFMS) N-Glycan Kits with an Andrew pipetting robot that... Read more

Waters UPLC and Mass Spectrometry Systems Approved for In-Vitro Diagnostic use in Brazil

Clinical laboratories now have access to enhanced levels of selectivity, sensitivity, and versatility from Waters’ newest UPLC-MS/MS technologies MILFORD, Mass.–(BUSINESS WIRE)–Jun. 8, 2017– Waters Corporation (NYSE: WAT) today announced that Brazil’sNational Health Surveillance Agency (ANVISA) has approved the Waters® ACQUITY® UPLC®, ACQUITY UPLC® I-Class System, and three mass spectrometers, the Xevo® TQD, Xevo TQ-S micro,... Read more

Agilent Technologies Introduces New GC/Q-TOF System Enabling Greater Exploration of Unknown Chemical Samples

Third-Generation Instrument Delivers Enhanced Analytical Performance and Unique Capabilities SANTA CLARA, Calif., June 6, 2017 Agilent Technologies Inc. (NYSE: A) today introduced a new high-resolution, accurate-mass system designed for laboratories doing food and environmental testing, life science research, forensics and chemical analysis. The Agilent 7250 GC/G-TOF system combines gas chromatography and quadrupole time-of-flight mass spectrometry... Read more